beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-D-GalpNAc

Term ID

CHEBI:71053

Synonyms

beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-D-GalNAc
beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactopyranose
beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-N-acetyl-D-galactosamine
D-galactopyranose, O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-
Galb1-4GlcNAcb1-3GalNAc
Galbeta1-4GlcNAcbeta1-3GalNAc
O-beta-D-galactopyranosyl-(1->4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-D-galactopyranose

Definition

A linear amino trisaccharide consisting of a chain of β-D-galactose, N-acetyl-β-D-glucosamine and N-acetyl-D-galactosamine residues linked sequentially (1→4) and (1→3).

References

glygen:G73971ME
glytoucan:G73971ME
pubmed:19443021
pubmed:25568069
pubmed:31537530

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-D-GalpNAc

Phenotype where environments contain beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-D-GalpNAc

Phenotype modified by environments containing beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-D-GalpNAc

Phenotype affecting beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-D-GalpNAc

Human Disease Model